Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$149M |
| 2 |
NVIDIA
NVDA
|
+$102M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$89.1M |
| 4 |
Comcast
CMCSA
|
+$71.1M |
| 5 |
Progressive
PGR
|
+$69.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$83.3M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$76.9M |
| 3 |
Coca-Cola
KO
|
+$56.4M |
| 4 |
Broadcom
AVGO
|
+$49.5M |
| 5 |
Lam Research
LRCX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.82% |
| 2 | Healthcare | 20.59% |
| 3 | Consumer Discretionary | 12.23% |
| 4 | Financials | 6.67% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Vertiv
VRT
$105B
| $514K | ﹤0.01% |
10,707
-50,268
| -82% | -$2.14M |
|
702
A.O. Smith
AOS
$8.7B
| $514K | ﹤0.01% |
6,233
-371
| -6% | -$27.4K |
|
703
Arista Networks
ANET
$238B
| $514K | ﹤0.01% |
8,724
-156,072
| -95% | -$8.2M |
|
704
Ultragenyx Pharmaceutical
RARE
$2.55B
| $509K | ﹤0.01% |
10,635
-754
| -7% | -$29.2K |
|
705
Home Depot
HD
$355B
| $507K | ﹤0.01% |
+1,464
| New | +$453K |
|
706
International Paper
IP
$22B
| $492K | ﹤0.01% |
13,615
+178
| +1% | +$6.22K |
|
707
NeoGenomics
NEO
$2.13B
| $483K | ﹤0.01% |
29,833
-118,513
| -80% | -$1.94M |
|
708
Bausch Health
BHC
$2.34B
| $445K | ﹤0.01% |
55,223
-34,939
| -39% | -$254K |
|
709
Principal Financial Group
PFG
$24.3B
| $444K | ﹤0.01% |
5,647
-15,983
| -74% | -$1.16M |
|
710
BioNTech
BNTX
$23.5B
| $431K | ﹤0.01% |
+4,083
| New | +$411K |
|
711
Korn Ferry
KFY
$4.28B
| $428K | ﹤0.01% |
7,219
-63,329
| -90% | -$3.23M |
|
712
Hanover Insurance
THG
$7.98B
| $428K | ﹤0.01% |
3,523
-10,976
| -76% | -$1.3M |
|
713
Treace Medical Concepts
TMCI
$309M
| $427K | ﹤0.01% |
33,520
-16,442
| -33% | -$166K |
|
|
HPP
714
Hudson Pacific Properties
HPP
$779M
| $427K | ﹤0.01% |
6,558
+343
| +6% | +$15.1K |
|
715
WEX
WEX
$6.31B
| $421K | ﹤0.01% |
+2,165
| New | +$393K |
|
|
CTLT
716
DELISTED
CATALENT, INC.
CTLT
| $419K | ﹤0.01% |
9,321
-227
| -2% | -$9.18K |
|
717
Morgan Stanley
MS
$340B
| $418K | ﹤0.01% |
4,483
+1,280
| +40% | +$102K |
|
718
Norfolk Southern
NSC
$75.1B
| $405K | ﹤0.01% |
1,712
-64,018
| -97% | -$13.4M |
|
719
Oracle
ORCL
$423B
| $404K | ﹤0.01% |
+3,834
| New | +$418K |
|
720
UDR
UDR
$12.3B
| $399K | ﹤0.01% |
10,410
+532
| +5% | +$18.5K |
|
721
T. Rowe Price
TROW
$24.3B
| $385K | ﹤0.01% |
3,572
+347
| +11% | +$34.6K |
|
722
Fortinet
FTNT
$117B
| $374K | ﹤0.01% |
6,386
-147,302
| -96% | -$8.14M |
|
723
Alnylam Pharmaceuticals
ALNY
$29.3B
| $373K | ﹤0.01% |
1,951
+65
| +3% | +$11.1K |
|
724
Goldman Sachs
GS
$303B
| $329K | ﹤0.01% |
854
-579
| -40% | -$193K |
|
725
ConocoPhillips
COP
$141B
| $328K | ﹤0.01% |
2,828
-278
| -9% | -$32.5K |
|
Similar funds
Ray Dalio's Q4 2023 Portfolio in Review
As of Q4 2023, Ray Dalio held 827 positions worth $17.9B, up 8% from $16.5B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ray Dalio's Q4 2023 filing shows 87 new, 260 increased, 385 reduced and 85 closed positions. Its largest new stake was iShares MSCI Brazil ETF: 2,750,734 shares worth $96.2M. The largest sale was Costco, an estimated $83.3M.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Ray Dalio's largest Q4 2023 buy was iShares MSCI Brazil ETF: 2,750,734 shares worth $96.2M.
- Ray Dalio added most to Eli Lilly in Q4 2023, an estimated $149M increase.
- Ray Dalio's biggest Q4 2023 reduction was Costco, cutting an estimated $83.3M.
- Ray Dalio fully exited Netflix in Q4 2023, selling an estimated $35.9M.
- Ray Dalio's ten largest holdings make up 31% of its $17.9B portfolio in Q4 2023.
- Ray Dalio opened 87 new positions and closed 85 in Q4 2023.
- Ray Dalio's portfolio value rose 8% quarter-over-quarter to $17.9B.
Based on Bridgewater Associates's 13F filing for Q4 2023, filed 14 Feb 2024.